Speakers: Nancy Devlin, Michael Herdman, Bram Roudjik, Nan Luo and Janine Verstraete at the 12th HTAsiaLink Conference 2025 on stage.
🌏 At #HTAsiaLink2025, we proudly sponsored a pre-conference workshop on measuring & valuing children’s HRQoL for HTA.
Highlights included hands-on sessions with EQ-5D-Y for children/adolescents & EQ-TIPS for infants/toddlers.
@prof-nancy-devlin.bsky.social
(cont)
on health technology assessment and support evidence-informed health policy in Asia. 🚀
#HITAP #ACE #HTAsiaLink2025 #HTAsiaLink #HealthTechnologyAssessment #HTA
At #HTAsiaLink2025, the Board and members gathered for their annual meeting to reflect on progress, set future directions, and strengthen collaboration. The network also welcomed its newly elected President and Vice President. As secretariat and editorial team, HITAP is honored to support evidence-informed policies for better health systems.
At #HTAsiaLink2025, the Board and members gathered for their annual meeting to reflect on progress, set future directions, and strengthen collaboration. The network also welcomed its newly elected President and Vice President. As secretariat and editorial team, HITAP is honored to support evidence-informed policies for better health systems.
At #HTAsiaLink2025, the Board and members gathered for their annual meeting to reflect on progress, set future directions, and strengthen collaboration. The network also welcomed its newly elected President and Vice President. As secretariat and editorial team, HITAP is honored to support evidence-informed policies for better health systems.
🔸 As secretariat and editorial team, HITAP is honored to support evidence-informed policies for better health systems. 🌏
#HITAP #HTAsiaLink2025 #HealthTechnologyAssessment #HTA #HealthPolicy #network #colloboration
At #HTAsiaLink2025, the Board and members gathered for their annual meeting to reflect on progress, set future directions, and strengthen collaboration. The network also welcomed its newly elected President and Vice President. As secretariat and editorial team, HITAP is honored to support evidence-informed policies for better health systems.
At #HTAsiaLink2025, the Board and members gathered for their annual meeting to reflect on progress, set future directions, and strengthen collaboration. The network also welcomed its newly elected President and Vice President. As secretariat and editorial team, HITAP is honored to support evidence-informed policies for better health systems.
At #HTAsiaLink2025, the Board and members gathered for their annual meeting to reflect on progress, set future directions, and strengthen collaboration. The network also welcomed its newly elected President and Vice President. As secretariat and editorial team, HITAP is honored to support evidence-informed policies for better health systems.
🔹 At #HTAsiaLink2025, the Board and members gathered for their annual meeting to reflect on progress, set future directions, and strengthen collaboration. The network also welcomed its newly elected President and Vice President.
As the 12th #HTAsiaLink Conference 2025 came to a close, HITAP reflected on the valuable connections and collaborations strengthened across the region. We thank our HITAP team for their contributions—sharing insights, engaging in discussions, and advancing the HTA network. Looking ahead, we are excited for the 13th #HTAsiaLink2026 in Taipei, Taiwan—continuing the journey of collaboration, knowledge exchange, and regional impact. See you next year!
As the 12th #HTAsiaLink Conference 2025 came to a close, HITAP reflected on the valuable connections and collaborations strengthened across the region. We thank our HITAP team for their contributions—sharing insights, engaging in discussions, and advancing the HTA network. Looking ahead, we are excited for the 13th #HTAsiaLink2026 in Taipei, Taiwan—continuing the journey of collaboration, knowledge exchange, and regional impact. See you next year!
As the 12th #HTAsiaLink Conference 2025 came to a close, HITAP reflected on the valuable connections and collaborations strengthened across the region. We thank our HITAP team for their contributions—sharing insights, engaging in discussions, and advancing the HTA network. Looking ahead, we are excited for the 13th #HTAsiaLink2026 in Taipei, Taiwan—continuing the journey of collaboration, knowledge exchange, and regional impact. See you next year!
As the 12th #HTAsiaLink Conference 2025 came to a close, HITAP reflected on the valuable connections and collaborations strengthened across the region. We thank our HITAP team for their contributions—sharing insights, engaging in discussions, and advancing the HTA network. Looking ahead, we are excited for the 13th #HTAsiaLink2026 in Taipei, Taiwan—continuing the journey of collaboration, knowledge exchange, and regional impact. See you next year!
The 12th #HTAsiaLink2025 wrapped up with strengthened connections and collaborations across the region. 🌏
Thank you to the HITAP team for driving evidence-informed health policy—and see you next year at #HTAsiaLink2026 in Taipei, Taiwan! ✈️👋
At #HTAsiaLink2025, Dr. Yot Teerawattananon (HITAP) spoke in Plenary 3: Translating HTA into Impactful Results – Value-Based Healthcare (VBHC), moderated by Dr. Li-Ying Huang (Center for Drug Evaluation). Speakers shared insights on implementing VBHC: Dr. Joanne Yoong (ISPOR) highlighted VBHC through a Health Economics and Outcomes Research (HEOR) perspective. Dr. Wija Oortwijn (Radboud University Medical Center) discussed value frameworks for resource allocation and hospital-based HTA. Dr. Yot Teerawattananon (HITAP) shared Thailand’s case studies showcasing HTA in action, including impacts and challenges. Ms. Liang Lin (ACE) presented Singapore’s HTA journey and real-world applications. The session highlighted how HTA informs decisions that improve health outcomes, emphasizing patient-centered approaches, sustainable solutions, and translating evidence into actionable policy.
At #HTAsiaLink2025, Dr. Yot Teerawattananon (HITAP) spoke in Plenary 3: Translating HTA into Impactful Results – Value-Based Healthcare (VBHC), moderated by Dr. Li-Ying Huang (Center for Drug Evaluation). Speakers shared insights on implementing VBHC: Dr. Joanne Yoong (ISPOR) highlighted VBHC through a Health Economics and Outcomes Research (HEOR) perspective. Dr. Wija Oortwijn (Radboud University Medical Center) discussed value frameworks for resource allocation and hospital-based HTA. Dr. Yot Teerawattananon (HITAP) shared Thailand’s case studies showcasing HTA in action, including impacts and challenges. Ms. Liang Lin (ACE) presented Singapore’s HTA journey and real-world applications. The session highlighted how HTA informs decisions that improve health outcomes, emphasizing patient-centered approaches, sustainable solutions, and translating evidence into actionable policy.
At #HTAsiaLink2025, Dr. Yot Teerawattananon (HITAP) spoke in Plenary 3: Translating HTA into Impactful Results – Value-Based Healthcare (VBHC), moderated by Dr. Li-Ying Huang (Center for Drug Evaluation: CDE).
📌 Follow us for more insights and highlights from HITAP at #HTAsiaLink2025.
#HITAP #HTAsiaLink #HealthTechnologyAssessment #HTA #AP-7D #tool #research #survey #HealthOutcome
Dr. Yot Teerawattananon from HITAP joined Prof. Nan Luo (NUS), Dr. Morii Yasuhiro (Center for Outcomes Research and Economic Evaluation for Health: C2H), and Prof. Jeonghoon Ahn (Ewha Womans University) in Sharing Session 2 at #HTAsiaLink2025 to discuss the Asia-Preference-Based Measure-7 Dimension (AP-7D)—a novel, region-specific preference-based measure (PBM) developed by HTAsiaLink and the Center for Outcomes Research and Economic Evaluation for Health (C2H) in Japan. The AP-7D aims to better reflect values relevant to Asian populations. The session focused ongoing valuation surveys across countries and the recent updates on AP-7D, paving the way for a deeper understanding of how health preferences differ across the region and how these insights can inform HTA and policy decisions.
Dr. Yot Teerawattananon from HITAP joined Prof. Nan Luo (NUS), Dr. Morii Yasuhiro (Center for Outcomes Research and Economic Evaluation for Health: C2H), and Prof. Jeonghoon Ahn (Ewha Womans University) in Sharing Session 2 at #HTAsiaLink2025 to discuss the Asia-Preference-Based Measure-7 Dimension (AP-7D)—a novel, region-specific preference-based measure (PBM) developed by HTAsiaLink and the Center for Outcomes Research and Economic Evaluation for Health (C2H) in Japan. The AP-7D aims to better reflect values relevant to Asian populations. The session focused ongoing valuation surveys across countries and the recent updates on AP-7D, paving the way for a deeper understanding of how health preferences differ across the region and how these insights can inform HTA and policy decisions.
Dr. Yot Teerawattananon from HITAP joined Prof. Nan Luo (NUS), Dr. Morii Yasuhiro (Center for Outcomes Research and Economic Evaluation for Health: C2H), and Prof. Jeonghoon Ahn (Ewha Womans University) in Sharing Session 2 at #HTAsiaLink2025 to discuss the Asia-Preference-Based Measure-7 Dimension (AP-7D)—a novel, region-specific preference-based measure (PBM) developed by HTAsiaLink and the Center for Outcomes Research and Economic Evaluation for Health (C2H) in Japan. The AP-7D aims to better reflect values relevant to Asian populations. The session focused ongoing valuation surveys across countries and the recent updates on AP-7D, paving the way for a deeper understanding of how health preferences differ across the region and how these insights can inform HTA and policy decisions.
Dr. Yot Teerawattananon from HITAP joined Prof. Nan Luo (NUS), Dr. Morii Yasuhiro (Center for Outcomes Research and Economic Evaluation for Health: C2H), and Prof. Jeonghoon Ahn (Ewha Womans University) in Sharing Session 2 at #HTAsiaLink2025 to discuss the Asia-Preference-Based Measure-7 Dimension (AP-7D)—a novel, region-specific preference-based measure (PBM) developed by HTAsiaLink and the Center for Outcomes Research and Economic Evaluation for Health (C2H) in Japan. The AP-7D aims to better reflect values relevant to Asian populations. The session focused ongoing valuation surveys across countries and the recent updates on AP-7D, paving the way for a deeper understanding of how health preferences differ across the region and how these insights can inform HTA and policy decisions.
Dr. Yot Teerawattananon from HITAP joined Prof. Nan Luo (NUS), Dr. Morii Yasuhiro (Center for Outcomes Research and Economic Evaluation for Health: C2H), and Prof. Jeonghoon Ahn (Ewha Womans University) in Sharing Session 2 at #HTAsiaLink2025 (cont)
🎉 Congratulations to our HITAPers at the #HTAsiaLink2025! 🎉
We are proud to celebrate our team members who received awards for their oral and poster presentations this year’s conference in Singapore.
🎉 Stay tuned to see who wins the poster and oral presentation tomorrow, sending our full support to the team!
📌 HITAP continue to share our contributions at #HTAsiaLink2025.
#HITAP #HTAsiaLink #HealthTechnologyAssessment #HTA #equity #DCEA
A Warm Welcome to the 12th #HTAsiaLink2025 in Singapore! Under the theme “Unlocking Value through Health Technology Assessment (HTA) in Asia: Forging Ahead Together,” this year’s gathering celebrates both the 12th HTAsiaLink Conference and the 10th anniversary of Singapore’s Agency for Care Effectiveness (ACE). Together, these milestones reflect a decade of progress in advancing HTA and strengthening collaboration across the region. Dr. Yot Teerawattananon from HITAP, delivered the opening speech in the Welcome Dinner, setting the tone for meaningful exchanges and collective learning throughout the conference.
Dr. Yot Teerawattananon, HITAP, delivered opening speech in the Welcome Dinner, setting the tone for meaningful exchanges and collective learning throughout the conference.
🚀 More highlights from the 12th #HTAsiaLink2025 coming soon—stay tuned!
#HITAP #HTAsiaLink #HealthTechnologyAssessment #HTA
A Warm Welcome to the 12th #HTAsiaLink2025 in Singapore! Under the theme “Unlocking Value through Health Technology Assessment (HTA) in Asia: Forging Ahead Together,” this year’s gathering celebrates both the 12th HTAsiaLink Conference and the 10th anniversary of Singapore’s Agency for Care Effectiveness (ACE). Together, these milestones reflect a decade of progress in advancing HTA and strengthening collaboration across the region. Dr. Yot Teerawattananon from HITAP, delivered the opening speech in the Welcome Dinner, setting the tone for meaningful exchanges and collective learning throughout the conference.
🌟 A Warm Welcome to the 12th #HTAsiaLink2025 in Singapore! 🌏
Under the theme “Unlocking Value through Health Technology Assessment (HTA) in Asia: Forging Ahead Together,” this year’s gathering celebrates both the 12th HTAsiaLink Conference
(cont)
At #HTAsiaLink2025, Dr. Wanrudee Isaranuwatchai, HITAP, moderated Plenary 1 “Exploring the Multiverse of Healthcare through #HTA: Diverse Perspectives, Unified Outcomes”, where global experts explored diverse HTA methods, equity, harmonization, and patient perspectives—towards shared outcomes.
At #HTAsiaLink2025, Dr. Wanrudee Isaranuwatchai, HITAP, moderated Plenary 1 “Exploring the Multiverse of Healthcare through #HTA: Diverse Perspectives, Unified Outcomes”, where global experts explored diverse HTA methods, equity, harmonization, and patient perspectives—towards shared outcomes.
At #HTAsiaLink2025, Dr. Wanrudee Isaranuwatchai, HITAP, moderated Plenary 1 “Exploring the Multiverse of Healthcare through #HTA: Diverse Perspectives, Unified Outcomes”, where global experts explored diverse HTA methods, equity, harmonization, and patient perspectives—towards shared outcomes.
At #HTAsiaLink2025, Dr. Wanrudee Isaranuwatchai, HITAP, moderated Plenary 1 “Exploring the Multiverse of Healthcare through #HTA: Diverse Perspectives, Unified Outcomes”, where global experts explored diverse HTA methods, equity, harmonization, and patient perspectives—towards shared outcomes. 💡
Dr. Wanrudee Isaranuwatchai (HITAP), along with Prof. Mark Jit (New York University) and Prof. Alex Cook (NUS), speakers at Sharing Session 1 at #HTAsiaLink2025, explored how epidemiological models can guide policy for emerging and pandemic infectious diseases. The session also highlighted the need for clear standards in evidence and reporting to make models more useful for health technology assessment (HTA) and policy decisions. Stronger standards mean better evidence and greater impact for populations across Asia. Stay tuned for HITAP’s contribution at the HTAsiaLink Conference 2025.
Dr. Wanrudee Isaranuwatchai (HITAP), along with Prof. Mark Jit (New York University) and Prof. Alex Cook (NUS), speakers at Sharing Session 1 at #HTAsiaLink2025, explored how epidemiological models can guide policy for emerging and pandemic infectious diseases. The session also highlighted the need for clear standards in evidence and reporting to make models more useful for health technology assessment (HTA) and policy decisions. Stronger standards mean better evidence and greater impact for populations across Asia. Stay tuned for HITAP’s contribution at the HTAsiaLink Conference 2025.
Dr. Wanrudee Isaranuwatchai (HITAP), along with Prof. Mark Jit (New York University) and Prof. Alex Cook (NUS), speakers at Sharing Session 1 at #HTAsiaLink2025, explored how epidemiological models can guide policy for emerging and pandemic infectious diseases. The session also highlighted the need for clear standards in evidence and reporting to make models more useful for health technology assessment (HTA) and policy decisions. Stronger standards mean better evidence and greater impact for populations across Asia. Stay tuned for HITAP’s contribution at the HTAsiaLink Conference 2025.
The session highlighted the need for clear standards to make models more useful for HTA and policy decisions.
#HITAP #HTAsiaLink2025 #HTAsiaLink #HealthTechnologyAssessment #HTA
Dr. Wanrudee Isaranuwatchai (HITAP), along with Prof. Mark Jit (New York University) and Prof. Alex Cook (NUS), speakers at Sharing Session 1 at #HTAsiaLink2025, explored how epidemiological models can guide policy for emerging and pandemic infectious diseases. The session also highlighted the need for clear standards in evidence and reporting to make models more useful for health technology assessment (HTA) and policy decisions. Stronger standards mean better evidence and greater impact for populations across Asia. Stay tuned for HITAP’s contribution at the HTAsiaLink Conference 2025.
Dr. Wanrudee Isaranuwatchai (HITAP), along with Prof. Mark Jit (New York University) and Prof. Alex Cook (NUS), speakers at Sharing Session 1 at #HTAsiaLink2025, explored how epidemiological models can guide policy for emerging and pandemic infectious diseases. The session also highlighted the need for clear standards in evidence and reporting to make models more useful for health technology assessment (HTA) and policy decisions. Stronger standards mean better evidence and greater impact for populations across Asia. Stay tuned for HITAP’s contribution at the HTAsiaLink Conference 2025.
Dr. Wanrudee Isaranuwatchai (HITAP), with Prof. Mark Jit (NYU) and Prof. Alex Cook (NUS), explored how epidemiological models can guide policy for emerging and pandemic infectious diseases at Sharing Session 1, #HTAsiaLink2025.
📍 Follow us for more on HITAP’s contributions at #HTAsiaLink2025, 20–22 August 2025 in Singapore.
#HITAP #HTAsiaLink #HealthTechnologyAssessment #HTA #equity #DCEA
🔹 This session underscores HITAP's role in advancing evidence-informed across the region.
This is just the beginning. Stay tuned for more updates from #HTAsiaLink2025 🚀
#HITAP #HTAsiaLink #HealthTechnologyAssessment #HTA #Kidneydisease
How can we ensure that patients with kidney failure receive life-saving care under Universal Health Coverage (UHC), and that policies are grounded in evidence? At today’s HTAsiaLink 2025 pre-conference, HITAP hosted the workshop “Addressing Kidney Failure under UHC: How to Conduct Economic Evaluation to Inform Policy” to explore this question. Facilitated by Khansa, the workshop guided participants through generating economic evidence for kidney replacement therapy in end-stage kidney disease—starting with Brandon on defining decision problems, Siobhan on selecting approaches and models, and Chotika on data inputs for economic evaluations. The interactive format invited participants to share perspectives and experiences, helping link best-practice guidelines with local contexts to inform stronger policy decisions. This session underscores HITAP’s role in advancing evidence-informed across the region.
🔹 At today’s #HTAsiaLink2025 pre-conference, @hitap.bsky.social hosted the workshop “Addressing Kidney Failure under UHC: How to Conduct Economic Evaluation to Inform Policy” to explore this question.
💡 @hitap.bsky.social is proud to contribute to advancing patient-centered HTA. 🌏
📍 More HITAP daily highlights from #HTAsiaLink2025 coming soon—stay tuned!
#HITAP #HTAsiaLink #HealthTechnologyAssessment #HTA
Patients bring unique perspectives and experiences that can strengthen health technology assessment (HTA). Three HITAP staff — Ms. Jiratorn Sutawong, Ms. Supasuda Posoree, and Ms. Siriyada Kitbamrung — spoke at the pre-conference workshop at the HTAsiaLink 2025 Conference in Singapore, “Voices to Action – The Value of Involving Patients in HTA,” sharing insights from Thailand on patient involvement in HTA. Co-hosted by the Agency for Care Effectiveness (ACE) and HTAi Patient & Citizen Involvement in HTA Interest Group (HTAi PCIG), the session explored tools and methods to embed patient perspectives in policy, and sparked discussion on approaches like patient preference studies to ensure decisions reflect what matters most. HITAP is proud to contribute to advancing patient-centered HTA.
Patients bring unique perspectives and experiences that can strengthen health technology assessment (HTA). Three HITAP staff — Ms. Jiratorn Sutawong, Ms. Supasuda Posoree, and Ms. Siriyada Kitbamrung — spoke at the pre-conference workshop at the HTAsiaLink 2025 Conference in Singapore, “Voices to Action – The Value of Involving Patients in HTA,” sharing insights from Thailand on patient involvement in HTA. Co-hosted by the Agency for Care Effectiveness (ACE) and HTAi Patient & Citizen Involvement in HTA Interest Group (HTAi PCIG), the session explored tools and methods to embed patient perspectives in policy, and sparked discussion on approaches like patient preference studies to ensure decisions reflect what matters most. HITAP is proud to contribute to advancing patient-centered HTA.
Patients bring unique perspectives and experiences that can strengthen health technology assessment (HTA). Three HITAP staff — Ms. Jiratorn Sutawong, Ms. Supasuda Posoree, and Ms. Siriyada Kitbamrung — spoke at the pre-conference workshop at the #HTAsiaLink2025, (cont)
The 12th HTAsiaLink Conference 2025 is coming to Singapore!
Join HTA leaders from across Asia Pacific to explore the power of collaboration in unlocking value in healthcare systems.
🔗 Register now – open to members & non-members: www.htasialink-conference2025.com
#HTAsiaLink2025 #HTA
